Fusion Acquisition Corp. (FUSE.U), announced the pricing of their upsized $305 million SPAC IPO this evening and the units are expected to begin trading tomorrow, Friday, June 26th, under the symbol NYSE: FUSE.U
Fusion Acquisition Corp. intends to focus on companies with an enterprise value of approximately $750 million to $3 billion that are applying, providing or changing technology within the fintech or asset and wealth management sectors. The Fusion team will be led by Jim Ross, the former Chairman of the global SPDR exchange-traded fund (“SPDR ETF”). Mr Ross will be Fusion’s non-Executive Chairman and will be joined by John James, as CEO and Director.
Total SPAC deal count for 2020 year-to-date is now 34 with $10.803 billion in gross proceeds raised. The offering is anticipated to close on Tuesday, June 30, 2020.
Cantor Fitzgerald & Co. acted as sole book-running manager of the offering. Odeon Capital Group, LLC acted as co-manager. White & Case LLP, and Ellenoff Grossman & Schole LLP, were issuer’s counsel and underwriter’s counsel, respectively. WithumSmith+Brown, PC acted as auditor.
Below is a daily summary of links to the latest SPAC news and rumors gathered across the web. Latest SPAC News: NYSE president says IPO proceeds fall more than 90% while Nasdaq president remains hopeful for 2023, and Giuliani brothers sell pharma stocks as they invest in biotech SPACs NYSE president says IPO proceeds fall...
InterPrivate II Acquisition Corp. (NYSE:IPVA) disclosed this morning that it has restructured its bonus share agreement in connection to its proposed merger with carsharing marketplace Getaround. The parties previously agreed to reserve and set aside the bonus shares, consisting of 9,333,333 shares, to be allocated to the non-redeeming public stockholders, the designees of EarlyBirdCapital and the...
Iris Acquisition Corp. (NASDAQ:IRAA) has entered into a definitive agreement to combine with biotech firm Liminatus at an enterprise value of $334 million. La Palma, California-based Liminatus is a clinical-stage drug developer working on a range of cancer treatments utilizing both preventative vaccines and CAR-T therapies. The combined company is expected to trade on the...
Lakeshore Acquisition Corp. I (NASDAQ:LAAA) announced this morning that it has entered into a non-redemption agreement and amended its purchaser support agreement with initial shareholders in connection to its proposed merger with medical device company ProSomnus. The SPAC entered into non-redemption agreements with certain institutional investors for an aggregate of 200,339 shares of the purchaser. These investors...
The companies and sponsors of six SPAC deals are set to see their lock-ups expire before the end of the year. This is a relatively small monthly total as the wave of deals from 2020 and 2021 are still hitting this milestone. The list nonetheless includes some major names starting with Forafric (NASDAQ:AFRI), which is...